About Plexon Inc
Plexon is a pioneer and leading innovator of custom high performance solutions for data acquisition, behavioral research and advanced analysis specifically designed for neuroscience research. Our equipment and solutions lay the foundation for work performed around the globe in fields such as basic science, Brain-Machine Interfaces (BMI), neurodegenerative diseases, addictive behaviors and neuroprosthetics.
Plexon’s mission is to be an investigator’s most dependable research partner. To support that mission, we have built the following robust solutions that address many aspects of the most challenging areas in research:
- Our flagship OmniPlex® Neural Data Acquisition System,
- Our advanced Behavioral Research Systems, CinePlex® and CineLyzer®
- Our innovative PlexBright® Optogenetic Stimulation System.
Plexon’s customers represent some of the most progressive domestic and international academic facilities, research hospitals, pharmaceutical companies and governmental laboratories. Based on research utilizing Plexon products, those labs have published thousands of articles – a great many are found on the pages of neuroscience’s most prestigious peer-reviewed journals such as Science, Nature and Neuron.
Founded in 1983 in Dallas, Texas by Harvey Wiggins, Plexon (under the initial name of Spectrum Scientific) has grown from a one-person shop to a full team of innovative engineers, biophysicists and neuroscientists with highly specialized expertise focused entirely on neuroscience research. Over the years, Plexon’s unwavering commitment to both our customers and the research industry has resulted in numerous corporate awards for customer satisfaction and impressive growth.
Harvey and the technology available through Plexon continue to be a driving force in the industry. Following 15 years of initial research and development, compounded by 30 years of commercial experience around the globe, Plexon remains steadfast in our commitment to servicing researchers exclusively.
You are invited to influence the next 30+ years of this story.